Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cost Effectiveness and Resource Allocation : C/E|April 2, 2019
A one stop shop for cost-effectiveness evidence? Recommendations for improving Disease Control PrioritiesMatthias Arnold, Susan Griffin, Jessica Ochalek, et al.
Pharmacoeconomics|August 29, 2020
Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity ApproachJessica Ochalek, Haiyin Wang, Yuanyuan Gu, et al.
BMJ Global Health|December 14, 2021
Concomitant health benefits package design and research prioritisation: development of a new approach and an application to MalawiLaetitia Schmitt, Jessica Ochalek, Karl Claxton, et al.
Journal of Benefit-Cost Analysis|December 7, 2020
Accounting for Timing when Assessing Health-Related PoliciesKarl Claxton, Miqdad Asaria, Collins Chansa, et al.
Applied Health Economics and Health Policy|August 23, 2022
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data ApproachSilvia Moler-Zapata, Noémi Kreif, Jessica Ochalek, et al.
Applied Health Economics and Health Policy|April 9, 2025
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision MakingMegha Rao, Simon Walker, Karl Claxton, et al.
BMJ Global Health|April 18, 2018
Supporting the development of a health benefits package in MalawiJessica Ochalek, Paul Revill, Gerald Manthalu, et al.
Value in Health Regional Issues|November 17, 2023
Estimation of Societal Values of Health States Preferences at the National Level for Low- and Middle-Income CountriesOscar Espinosa, Michael F Drummond, Luis-Esteban Orozco, et al.
Health Economics, Policy, and Law|February 18, 2026
Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?Peter Murphy, Susan Griffin, Simon Walker, et al.
Plos One|February 11, 2025
Health-related quality of life implications of plantar ulcers resulting from neuropathic damage caused by leprosy: An analysis from the trial of autologous blood products (TABLE trial) in NepalNaomi Kate Gibbs, Jessica Ochalek, Indra Bahadur Napit, et al.
Pageof 3